Confronting America’s Smoking Pandemic, Part 3: 1986–1999
May 4th 2016Dr. Alan Blum and Cancer Network have partnered to assemble a four-part slideshow series addressing the history of America’s smoking pandemic. Part 3 highlights a period of regulation and legislation against the tobacco industry, and litigation in the form of class action and state lawsuits.
11 Ways to Better Communicate With Your Colleagues
May 3rd 2016No matter where you practice medicine, if your duties include patient care then you are going to interact with other oncologists. In some cases you may question the quality of their care. Help your peers to become better physicians by respecting them first, then relaying your concerns to them. Here are some examples of how not to do it, paired with kinder, gentler alternatives.
FDA Approves RCC Drug, Prostate Cancer and Smoking Link: April News Roundup
April 29th 2016This slide show highlights some of the top stories of the month, including the approval of a new agent for RCC, a study that found declines in prostate cancer deaths have mirrored the declines in smoking rates, and more.
Silvia Formenti on the Promise of Combining Radiotherapy and Immunotherapy to Treat Cancer
April 15th 2016During the past decade, scientific evidence has emerged that shows that radiotherapy can induce: A) immunogenic cell death, a form of cancer cell death that is effectively signaling to the immune system; and B) a series of “danger” and pro-immunogenic signals that are sensed by the host’s immune system, and can be harnessed to reject the tumor.
Chemotherapy After Radiation Increases Survival for Low-Grade Glioma Patients
April 13th 2016The combination of chemotherapy and radiation therapy resulted in longer overall survival than radiation alone in certain patients with grade 2 gliomas, according to long-term results from a randomized trial.
FDA Allows Marketing of Tissue Containment System for Use in Power Morcellation
April 8th 2016While continuing to warn against use of laparoscopic power morcellators for the removal of uterus or uterine fibroids in most women, the FDA is allowing the marketing of a containment system for use with certain power morcellators to isolate tissue not suspected to be cancerous.